Skip to main content
. Author manuscript; available in PMC: 2007 Nov 21.
Published in final edited form as: Endocrinology. 2007 Feb 1;148(5):2016–2026. doi: 10.1210/en.2006-0602

Figure 2.

Figure 2

Urinary expression of kallikrein by ELISA in non-diabetic rats (Normal), diabetic rats treated with rAAV·LacZ (LacZ) and diabetic rats treated with rAAV·HK (HK) at various time points after treatment. Values are mean ± SEM (n=6 for each group); **P<0.01 vs. Normal; ## P<0.01 vs. LacZ.